Marco is an Instructor at Harvard Medical School and core scientist at Harvard Digestive Diseases Center (HDDC) where he offers training and consultation for cell metabolic analysis. He obtained his Ph.D. in Translational Medicine at University of Milano-Bicocca, studying Natural Killer (NK) cell and dendritic cell activation. In 2015 he joined the Zanoni lab studying how endogenous oxidized phospholipids, released during infectious and non-infectious conditions, sustain and enhance the inflammatory responses of phagocytes. His major interest is to elucidate the molecular mechanisms by which host-derived stressors rewire the metabolic status of both immune and non-immune cells and how this impacts the progression of chronic pathologies, such as atherosclerosis, obesity and colitis.

Valentina completed her M.Sc. in Biology and her Ph.D in Translational Medicine at the University of Milano-Bicocca, Italy. She joined the Zanoni lab as a graduate student working on the interaction of platelets and neutrophils in sepsis development. Also, she investigates the molecular mechanisms involved in NETosis induction during infections.

When not in the lab, Valentina likes following her passion for photography, and taking care of her indoor garden.

Sreya completed her B.Sc. and M.Sc. (Biochemistry) from University of Calcutta, India and received her Ph.D. (Immunology & Microbiology) from the University of Massachusetts Medical School, USA where she trained with Dr. Katherine A. Fitzgerald. In the Zanoni lab, she works on harnessing the capabilities of type III interferons in infections and cancer.

Outside of the lab, Sreya enjoys long drives, reading fiction, and experimenting with different cuisines.

Benedetta first joined the lab as a Master's student in 2017 working on type III IFNs in the context of respiratory superinfections. She is now a PhD student and her research is focused on host innate immunity at mucosal surfaces.

She loves playing cards and karaoke nights.

Carl earned his medical degree from St. John's Medical College, India and subsequently pursued his doctoral studies at the University of Oxford, UK on a Rhodes scholarship. He studied the molecular epidemiology of enteric fever in South Asia under Dr. Andrew Pollard, director of the Oxford Vaccine Group. He is currently a pediatric resident on the integrated research pathway, part of the Boston Combined Residency Program. In the Zanoni lab, he works on delineating the role of inflammatory chemokines in severe pneumonia and biomarkers of severe outcomes of pneumonia.

Outside of the lab, Carl enjoys running, biking and stand-up comedy. 

David performed his PhD in Immunology at Utrecht University in the Van Wijk lab and at the Rockefeller University in the Mucida lab. He completed pediatrics residency at Boston Children’s Hospital and Harvard Medical School concurrent with research at Harvard Medical School in the Kirchhausen lab, and in the Zon lab. He joined the Immunology Division at Boston Children's Hospital and Harvard Medical School and is jointly supervised by Drs. Nigrovic and Zanoni.

Giuliana joined the lab as an international Master student and she is working on type III interferons in infections and cancer. Outside the lab she enjoys cooking and hiking.

Océane obtained her PhD in immunology and microbiology at University Côte d’Azur in France. During her PhD in Laurent Boyer’s lab she studied the detection of RhoGTPases-activating toxins by the innate immune system. She joined the Zanoni lab in 2022 as a research fellow and is interested in the inflammatory response triggered by endogenous ligands.
During her free time she loves climbing and cooking.

Kautilya joined the Zanoni lab as a post-doctoral research fellow in March 2022. He completed

his Ph.D. from DBT-Institute of Life Sciences, India in 2021 where he focused on the

mechanism of protein aggregation biology and its implication in neurodegeneration and cancer.

After his Ph.D. he worked as research associate and contributed to elucidate the innate immune molecular mechanisms that control inflammation and viral infections. In the Zanoni lab he focuses on the development of new vaccine adjuvant formulations based on microbial ligands. He is also involved in deciphering the role of type III interferons in mucosal biology. Besides research, he loves travelling, watching movies, and playing football.  

​Daniel studied Medicine at the LMU and TU in Munich. From 2015 to 2017 he performed his MD thesis in the lab of Lars Koenig and Max Schnurr in the Division of Clinical Pharmacology at the LMU university hospital on cell death induction in tumor cells by RLR-ligands. He continued working there as a postdoc from 2018 to 2019 focusing on interferon biology. Since 2019 he is doing his residency in Internal Medicine and Gastroenterology in the Department of Medicine II at the university hospital of the LMU. He joined the Zanoni lab in 2022 to work on innate immune pathways related to intestinal inflammation.

When not in the lab, Daniel enjoys spending time with his family, playing tennis, ski touring and very mediocre surfing.